Department of Obstetrics and Gynecology, University of Texas Health San Antonio, 7703 Floyd Curl Dr, San Antonio, TX, 78229, USA.
Long School of Medicine, University of Texas Health San Antonio, San Antonio, TX, 78229, USA.
Reprod Sci. 2024 May;31(5):1345-1352. doi: 10.1007/s43032-023-01441-3. Epub 2024 Jan 3.
The purpose of this study was to determine whether utilization of assisted reproductive technology following clearance of endometrial intraepithelial neoplasia (EIN) or early endometrial cancer (EC) shortens time to conception (TTC) and reduces recurrence. Patients aged 18 to 45 with EIN or early EC who achieved pathologic response following progesterone treatment were identified via retrospective chart review. Study groups included patients who pursued ovulation induction (OI), in vitro fertilization (IVF), and spontaneous pregnancy. Primary outcomes were TTC and recurrence rate. Three hundred forty-six charts were reviewed, with 86 patients meeting inclusion criteria and 53 attempting pregnancy. Of those 53 patients, 11 became pregnant and seven had a live birth. Median times to pregnancy were 183 days for IVF, 54 days for OI, and 347 days for spontaneous conception (p < 0.05). No differences were seen in recurrence or progression based on attempted pregnancy method, nor with duration of fertility treatment. Forty-two of 86 patients (49%) were lost to follow-up. For patients with a history of treated EIN or EC, OI may decrease TTC. Larger prospective studies are needed to definitively answer this question. Although no differences in recurrence or progression were identified, the significant loss to follow-up rate in this study is concerning and warrants further investigation.
本研究旨在确定子宫内膜上皮内瘤变(EIN)或早期子宫内膜癌(EC)清除后,辅助生殖技术的应用是否能缩短受孕时间(TTC)并降低复发率。通过回顾性病历审查,确定了年龄在 18 至 45 岁之间、接受孕激素治疗后病理反应良好的 EIN 或早期 EC 患者。研究组包括接受排卵诱导(OI)、体外受精(IVF)和自然妊娠的患者。主要结局是 TTC 和复发率。共回顾了 346 份病历,其中 86 名患者符合纳入标准,53 名患者尝试怀孕。在这 53 名患者中,11 人怀孕,7 人活产。IVF 的妊娠中位时间为 183 天,OI 为 54 天,自然妊娠为 347 天(p<0.05)。尝试的妊娠方法、生育治疗的持续时间与复发或进展均无差异。86 名患者中有 42 名(49%)失访。对于有治疗过的 EIN 或 EC 病史的患者,OI 可能会缩短 TTC。需要更大的前瞻性研究来明确回答这个问题。尽管未发现复发或进展的差异,但本研究中显著的失访率令人担忧,需要进一步调查。